+735.2%
MRNA vs UPRO
+15.1%
+720.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | UPRO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.9% | -3.2% | -0.8% | -1.4% |
| 7D | -17.6% | -7.2% | -10.3% | -12.5% |
| 30D | -5.1% | -13.6% | +8.4% | +6.6% |
| 3M | +220.8% | -17.9% | +238.7% | +276.8% |
| 6M | +321.7% | -9.1% | +330.8% | +361.4% |
| YTD | +601.3% | +10.0% | +591.3% | +564.0% |
| 1Y | +735.2% | +17.2% | +718.0% | +641.7% |
| All | +735.2% | +15.1% | +720.1% | +641.7% |
Cumulative growth
Daily Returns
Daily percentage return beside UPRO.
Daily Out/Under-Performance
Portfolio return minus UPRO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UPRO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded UPRO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling